Sanctuary Advisors LLC Boosts Stock Holdings in The Clorox Company $CLX

Sanctuary Advisors LLC raised its holdings in The Clorox Company (NYSE:CLX) by 47.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,248 shares of the company’s stock after purchasing an additional 6,553 shares during the quarter. Sanctuary Advisors LLC’s holdings in Clorox were worth $2,098,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of CLX. State Street Corp grew its holdings in Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after acquiring an additional 282,794 shares during the period. Invesco Ltd. grew its stake in shares of Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after purchasing an additional 884,751 shares during the period. Geode Capital Management LLC increased its holdings in shares of Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after purchasing an additional 10,060 shares in the last quarter. Van ECK Associates Corp lifted its stake in shares of Clorox by 15.7% in the fourth quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after purchasing an additional 426,433 shares during the period. Finally, Two Sigma Investments LP boosted its holdings in Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 0.6%

CLX opened at $95.72 on Wednesday. The firm has a market cap of $11.57 billion, a P/E ratio of 15.54 and a beta of 0.54. The business’s fifty day simple moving average is $94.87 and its 200 day simple moving average is $103.98. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the company posted $1.45 EPS. The firm’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts anticipate that The Clorox Company will post 5.52 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Citigroup reduced their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Royal Bank Of Canada reduced their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. JPMorgan Chase & Co. lowered their target price on Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a report on Thursday, July 16th. Jefferies Financial Group cut their price target on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Finally, TD Cowen increased their price objective on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $103.40.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.63% of the stock is currently owned by corporate insiders.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.